State Board of Administration of Florida Retirement System’s BioXcel Therapeutics BTAI Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio BTAI Stock Details BTAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,070	Closed	-$202K	–	2317
2022 Q3	$202K	Hold	1,070	–	–	﹤0.01%	2058
2022 Q2	$226K	Buy	1,070 +332	+45%	+$69.8K	﹤0.01%	2062
2022 Q1	$247K	Hold	738	–	–	﹤0.01%	2079
2021 Q4	$240K	Hold	738	–	–	﹤0.01%	2150
2021 Q3	$358K	Hold	738	–	–	﹤0.01%	2015
2021 Q2	$343K	Buy	738 +389	+111%	+$212K	﹤0.01%	2070
2021 Q1	$241K	Buy	349 +51	+17%	+$41K	﹤0.01%	2139
2020 Q4	$220K	Sell	298 -55	-16%	-$42.8K	﹤0.01%	2136
2020 Q3	$245K	Buy	353 +92	+35%	+$69.1K	﹤0.01%	1974
2020 Q2	$222K	Buy	+261	New	+$170K	﹤0.01%	2011

Other funds holding BTAI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

State Board of Administration of Florida Retirement System's BTAI Position: Q4 2022 in Review

State Board of Administration of Florida Retirement System sold out of BioXcel Therapeutics (BTAI) in Q4 2022, closing a stake of 1,070 shares — an estimated $202K sold.

State Board of Administration of Florida Retirement System first reported a position in BTAI in Q2 2020 and held it in 10 quarters. The position peaked at $358K in Q3 2021. 83 funds tracked by Wall St. Rank hold BTAI as of Q4 2022.

State Board of Administration of Florida Retirement System reported no remaining BioXcel Therapeutics position as of Q4 2022 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 1,070 BioXcel Therapeutics shares in Q4 2022, an estimated $202K.
State Board of Administration of Florida Retirement System first reported a position in BioXcel Therapeutics in Q2 2020 and held it in 10 quarters.
State Board of Administration of Florida Retirement System's BioXcel Therapeutics position peaked at $358K in Q3 2021.
83 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q4 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q4 2022, filed 7 Feb 2023.